Yep, agree we will never get to use - except in partnership post FDA approval (assuming exit after P2 does not occur). It would be a sweetener for Pharma especially if they want it for another one of their projects.
Also the PRV has effectively been canned with sunsetting rules. A PRV can only be granted to a designated rare pediatric disease that was granted before 30/09/2024. Plus, No PRV can be granted post 30 September 2026, so limited timeframe to be of any use.
Yep, agree we will never get to use - except in partnership post...
-
- There are more pages in this discussion • 5,648 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
